941 related articles for article (PubMed ID: 32693755)
1. Relationship between Gut Microbiota, Gut Hyperpermeability and Obesity.
Gasmi A; Mujawdiya PK; Pivina L; Doşa A; Semenova Y; Benahmed AG; Bjørklund G
Curr Med Chem; 2021; 28(4):827-839. PubMed ID: 32693755
[TBL] [Abstract][Full Text] [Related]
2. [Physiological patterns of intestinal microbiota. The role of dysbacteriosis in obesity, insulin resistance, diabetes and metabolic syndrome].
Halmos T; Suba I
Orv Hetil; 2016 Jan; 157(1):13-22. PubMed ID: 26708682
[TBL] [Abstract][Full Text] [Related]
3. [Relationship between intestinal hyperpermeability and obesity].
Ságodi L; Sólyom E; Ságodi L; Almási A
Orv Hetil; 2022 Aug; 163(32):1261-1267. PubMed ID: 35933621
[TBL] [Abstract][Full Text] [Related]
4. Protective effect of quercetin on high-fat diet-induced non-alcoholic fatty liver disease in mice is mediated by modulating intestinal microbiota imbalance and related gut-liver axis activation.
Porras D; Nistal E; Martínez-Flórez S; Pisonero-Vaquero S; Olcoz JL; Jover R; González-Gallego J; García-Mediavilla MV; Sánchez-Campos S
Free Radic Biol Med; 2017 Jan; 102():188-202. PubMed ID: 27890642
[TBL] [Abstract][Full Text] [Related]
5. Gut Microbiota Mediates the Protective Effects of Dietary Capsaicin against Chronic Low-Grade Inflammation and Associated Obesity Induced by High-Fat Diet.
Kang C; Wang B; Kaliannan K; Wang X; Lang H; Hui S; Huang L; Zhang Y; Zhou M; Chen M; Mi M
mBio; 2017 May; 8(3):. PubMed ID: 28536285
[TBL] [Abstract][Full Text] [Related]
6. Microbial dysbiosis-induced obesity: role of gut microbiota in homoeostasis of energy metabolism.
Amabebe E; Robert FO; Agbalalah T; Orubu ESF
Br J Nutr; 2020 May; 123(10):1127-1137. PubMed ID: 32008579
[TBL] [Abstract][Full Text] [Related]
7. [Alteration of intestinal permeability: the missing link between gut microbiota modifications and inflammation in obesity?].
Genser L; Poitou C; Brot-Laroche É; Rousset M; Vaillant JC; Clément K; Thenet S; Leturque A
Med Sci (Paris); 2016 May; 32(5):461-9. PubMed ID: 27225918
[TBL] [Abstract][Full Text] [Related]
8. N-3 polyunsaturated fatty acids: An innovative strategy against obesity and related metabolic disorders, intestinal alteration and gut microbiota dysbiosis.
Bellenger J; Bellenger S; Escoula Q; Bidu C; Narce M
Biochimie; 2019 Apr; 159():66-71. PubMed ID: 30690133
[TBL] [Abstract][Full Text] [Related]
9. Gut microbiota-derived metabolites as key mucosal barrier modulators in obesity.
Wei YX; Zheng KY; Wang YG
World J Gastroenterol; 2021 Sep; 27(33):5555-5565. PubMed ID: 34588751
[TBL] [Abstract][Full Text] [Related]
10. The Roles of Inflammation, Nutrient Availability and the Commensal Microbiota in Enteric Pathogen Infection.
Stecher B
Microbiol Spectr; 2015 Jun; 3(3):. PubMed ID: 26185088
[TBL] [Abstract][Full Text] [Related]
11. Microbiota dysbiosis and barrier dysfunction in inflammatory bowel disease and colorectal cancers: exploring a common ground hypothesis.
Yu LC
J Biomed Sci; 2018 Nov; 25(1):79. PubMed ID: 30413188
[TBL] [Abstract][Full Text] [Related]
12. Intestinal Barrier in Human Health and Disease.
Di Tommaso N; Gasbarrini A; Ponziani FR
Int J Environ Res Public Health; 2021 Dec; 18(23):. PubMed ID: 34886561
[TBL] [Abstract][Full Text] [Related]
13. The intestinal microbiota fuelling metabolic inflammation.
Tilg H; Zmora N; Adolph TE; Elinav E
Nat Rev Immunol; 2020 Jan; 20(1):40-54. PubMed ID: 31388093
[TBL] [Abstract][Full Text] [Related]
14. Spermidine improves gut barrier integrity and gut microbiota function in diet-induced obese mice.
Ma L; Ni Y; Wang Z; Tu W; Ni L; Zhuge F; Zheng A; Hu L; Zhao Y; Zheng L; Fu Z
Gut Microbes; 2020 Nov; 12(1):1-19. PubMed ID: 33151120
[TBL] [Abstract][Full Text] [Related]
15. Altered Gut Microbiota: A Link Between Diet and the Metabolic Syndrome.
Velasquez MT
Metab Syndr Relat Disord; 2018 Sep; 16(7):321-328. PubMed ID: 29957105
[TBL] [Abstract][Full Text] [Related]
16. Neohesperidin attenuates obesity by altering the composition of the gut microbiota in high-fat diet-fed mice.
Lu JF; Zhu MQ; Zhang H; Liu H; Xia B; Wang YL; Shi X; Peng L; Wu JW
FASEB J; 2020 Sep; 34(9):12053-12071. PubMed ID: 32729978
[TBL] [Abstract][Full Text] [Related]
17. Gut Microbiota and Obesity: A Role for Probiotics.
Abenavoli L; Scarpellini E; Colica C; Boccuto L; Salehi B; Sharifi-Rad J; Aiello V; Romano B; De Lorenzo A; Izzo AA; Capasso R
Nutrients; 2019 Nov; 11(11):. PubMed ID: 31703257
[TBL] [Abstract][Full Text] [Related]
18. The metabolic and vascular protective effects of olive (Olea europaea L.) leaf extract in diet-induced obesity in mice are related to the amelioration of gut microbiota dysbiosis and to its immunomodulatory properties.
Vezza T; Rodríguez-Nogales A; Algieri F; Garrido-Mesa J; Romero M; Sánchez M; Toral M; Martín-García B; Gómez-Caravaca AM; Arráez-Román D; Segura-Carretero A; Micol V; García F; Utrilla MP; Duarte J; Rodríguez-Cabezas ME; Gálvez J
Pharmacol Res; 2019 Dec; 150():104487. PubMed ID: 31610229
[TBL] [Abstract][Full Text] [Related]
19. [Gut microbiota and immune crosstalk in metabolic disease].
Burcelin R
Biol Aujourdhui; 2017; 211(1):1-18. PubMed ID: 28682223
[TBL] [Abstract][Full Text] [Related]
20. Exploiting the Zonulin Mouse Model to Establish the Role of Primary Impaired Gut Barrier Function on Microbiota Composition and Immune Profiles.
Miranda-Ribera A; Ennamorati M; Serena G; Cetinbas M; Lan J; Sadreyev RI; Jain N; Fasano A; Fiorentino M
Front Immunol; 2019; 10():2233. PubMed ID: 31608059
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]